Discontinuation report ATENOLOL
| Report ID | 232358 |
| Drug Identification Number | 02238316 |
| Brand name | ATENOLOL |
| Common or Proper name | ATENOLOL |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATENOLOL |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-06-01 |
| Remaining supply date | 2024-06-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | There is no remaining supply |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-07-05 | French | Compare |
| v1 | 2024-07-05 | English | Compare |
Showing 1 to 2 of 2